Symbols / BLCO $17.12 -0.58%
BLCO Chart
About
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Instruments & Su | Market Cap | 6.08B |
| Enterprise Value | 11.03B | Income | -360.00M | Sales | 5.10B |
| Book/sh | 18.20 | Cash/sh | 1.08 | Dividend Yield | — |
| Payout | 0.00% | Employees | 13000 | IPO | — |
| P/E | — | Forward P/E | 16.16 | PEG | — |
| P/S | 1.19 | P/B | 0.94 | P/C | — |
| EV/EBITDA | 18.12 | EV/Sales | 2.16 | Quick Ratio | 0.84 |
| Current Ratio | 1.55 | Debt/Eq | 80.46 | LT Debt/Eq | — |
| EPS (ttm) | -1.02 | EPS next Y | 1.06 | EPS Growth | — |
| Revenue Growth | 9.80% | Earnings | 2026-04-29 | ROA | 0.85% |
| ROE | -5.39% | ROIC | — | Gross Margin | 59.81% |
| Oper. Margin | 11.25% | Profit Margin | -7.06% | Shs Outstand | 354.32M |
| Shs Float | 42.81M | Short Float | 7.35% | Short Ratio | 9.92 |
| Short Interest | — | 52W High | 18.91 | 52W Low | 10.45 |
| Beta | 0.58 | Avg Volume | 391.79K | Volume | 200.50K |
| Target Price | $18.64 | Recom | Hold | Prev Close | $17.22 |
| Price | $17.12 | Change | -0.58% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$18.64
Mean price target
2. Current target
$17.12
Latest analyst target
3. DCF / Fair value
$7.18
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$17.12
Low
$15.00
High
$21.00
Mean
$18.64
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-23 | main | HC Wainwright & Co. | Buy → Buy | $20 |
| 2026-02-19 | main | Citigroup | Buy → Buy | $21 |
| 2026-02-19 | main | Barclays | Equal-Weight → Equal-Weight | $20 |
| 2026-02-19 | main | Stifel | Hold → Hold | $16 |
| 2026-02-19 | main | Wells Fargo | Equal-Weight → Equal-Weight | $18 |
| 2026-02-17 | main | Stifel | Hold → Hold | $15 |
| 2026-01-05 | down | Evercore ISI Group | Outperform → In-Line | $18 |
| 2025-12-02 | up | Morgan Stanley | Equal-Weight → Overweight | $21 |
| 2025-11-14 | main | RBC Capital | Outperform → Outperform | $19 |
| 2025-11-14 | main | Wells Fargo | Equal-Weight → Equal-Weight | $17 |
| 2025-10-31 | main | Barclays | Equal-Weight → Equal-Weight | $17 |
| 2025-10-31 | main | HC Wainwright & Co. | Buy → Buy | $17 |
| 2025-10-30 | main | JP Morgan | Neutral → Neutral | $16 |
| 2025-10-30 | main | Evercore ISI Group | Outperform → Outperform | $18 |
| 2025-10-30 | main | Wells Fargo | Equal-Weight → Equal-Weight | $16 |
| 2025-10-30 | reit | Raymond James | Outperform → Outperform | $19 |
| 2025-10-07 | main | Evercore ISI Group | Outperform → Outperform | $17 |
| 2025-10-01 | init | Goldman Sachs | — → Neutral | $16 |
| 2025-08-01 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $13 |
| 2025-07-31 | main | HC Wainwright & Co. | Buy → Buy | $16 |
- Bausch + Lomb (NYSE:BLCO) CEO Purchases $251,958.00 in Stock - MarketBeat ue, 10 Mar 2026 22
- (BLCO) Investment Analysis and Advice (BLCO:CA) - Stock Traders Daily ue, 10 Mar 2026 16
- A Look At Bausch + Lomb (NYSE:BLCO) Valuation As Glaucoma Pipeline Webinar Draws Fresh Attention - simplywall.st ue, 10 Mar 2026 13
- Inside Bausch + Lomb’s glaucoma webinar on new treatments - Stock Titan Mon, 09 Mar 2026 11
- Is It Time To Reassess Bausch + Lomb (BLCO) After Its Recent Share Price Strength? - Yahoo Finance ue, 24 Feb 2026 08
- BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point? - The Motley Fool Wed, 03 Dec 2025 08
- Bausch And Lomb (NYSE:BLCO) Glaucoma Moves Catch Market Eyes Nyse Composite Today - Kalkine Media ue, 10 Mar 2026 20
- Bausch + Lomb Launches R&D Webinar Series Spotlighting Glaucoma Pipeline - TipRanks Mon, 09 Mar 2026 13
- Why Bausch + Lomb (BLCO) Stock Is Trading Up Today - Finviz hu, 11 Dec 2025 08
- Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats (NYSE:BLCO) - Seeking Alpha hu, 19 Feb 2026 08
- Bausch + Lomb Corporation (NYSE:BLCO) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat Fri, 06 Mar 2026 06
- 3 Reasons to Sell BLCO and 1 Stock to Buy Instead - Yahoo Finance Mon, 09 Feb 2026 08
- Digital lifestyles are turning eyes red – and one drop stands out - Stock Titan ue, 24 Feb 2026 08
- Trading Systems Reacting to (BLCO) Volatility - Stock Traders Daily Fri, 06 Mar 2026 14
- Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know - Yahoo Finance Mon, 20 Oct 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 4500 | 79556 | — | Purchase at price 17.68 per share. | ROSS THOMAS W SR | Director | — | 2026-03-03 00:00:00 | D |
| 1 | 4500 | — | — | Stock Award(Grant) at price 0.00 per share. | ROSS THOMAS W SR | Director | — | 2026-03-03 00:00:00 | D |
| 2 | 4300 | 76970 | — | Purchase at price 17.90 per share. | ALFONSO EDUARDO C. M.D. | Director | — | 2026-03-02 00:00:00 | D |
| 3 | 4300 | — | — | Stock Award(Grant) at price 0.00 per share. | ALFONSO EDUARDO C. M.D. | Director | — | 2026-03-02 00:00:00 | D |
| 4 | 4364 | 79883 | — | Purchase at price 18.30 per share. | VON ESCHENBACH ANDREW CHARLES | Director | — | 2026-02-27 00:00:00 | D |
| 5 | 4364 | — | — | Stock Award(Grant) at price 0.00 per share. | VON ESCHENBACH ANDREW CHARLES | Director | — | 2026-02-27 00:00:00 | D |
| 6 | 327102 | — | — | Stock Award(Grant) at price 0.00 per share. | SAUNDERS BRENT L. | Chief Executive Officer | — | 2026-02-25 00:00:00 | D |
| 7 | 52570 | — | — | Stock Award(Grant) at price 0.00 per share. | BAILEY AMBROSE ROBERT DOUGLAS J.D. | Officer | — | 2026-02-25 00:00:00 | D |
| 8 | 18253 | — | — | Stock Award(Grant) at price 0.00 per share. | MUNSCH FREDERICK JOHN | Officer | — | 2026-02-25 00:00:00 | D |
| 9 | 35046 | — | — | Stock Award(Grant) at price 0.00 per share. | HASHAD YEHIA | Officer | — | 2026-02-25 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -14.40M | -8.40M | -40.80M | -1.83M |
| TaxRateForCalcs | 0.15 | 0.15 | 0.40 | 0.26 |
| NormalizedEBITDA | 621.00M | 657.00M | 601.00M | 605.00M |
| TotalUnusualItems | -96.00M | -56.00M | -102.00M | -7.00M |
| TotalUnusualItemsExcludingGoodwill | -96.00M | -56.00M | -102.00M | -7.00M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -360.00M | -317.00M | -260.00M | 6.00M |
| ReconciledDepreciation | 421.00M | 436.00M | 382.00M | 379.00M |
| ReconciledCostOfRevenue | 1.89B | 1.72B | 1.50B | 1.38B |
| EBITDA | 525.00M | 601.00M | 499.00M | 598.00M |
| EBIT | 104.00M | 165.00M | 117.00M | 219.00M |
| NetInterestIncome | -409.00M | -384.00M | -268.00M | -140.00M |
| InterestExpense | 421.00M | 399.00M | 283.00M | 146.00M |
| InterestIncome | 12.00M | 15.00M | 15.00M | 6.00M |
| NormalizedIncome | -278.40M | -269.40M | -198.80M | 11.17M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -360.00M | -317.00M | -260.00M | 6.00M |
| TotalExpenses | 4.91B | 4.58B | 3.94B | 3.55B |
| TotalOperatingIncomeAsReported | 113.00M | 162.00M | 130.00M | 207.00M |
| DilutedAverageShares | 351.80M | 350.50M | 350.00M | 350.00M |
| BasicAverageShares | 351.80M | 350.50M | 350.00M | 350.00M |
| DilutedEPS | -0.90 | -0.74 | 0.02 | 0.52 |
| BasicEPS | -0.90 | -0.74 | 0.02 | 0.52 |
| DilutedNIAvailtoComStockholders | -360.00M | -317.00M | -260.00M | 6.00M |
| NetIncomeCommonStockholders | -360.00M | -317.00M | -260.00M | 6.00M |
| NetIncome | -360.00M | -317.00M | -260.00M | 6.00M |
| MinorityInterests | -8.00M | -12.00M | -12.00M | -9.00M |
| NetIncomeIncludingNoncontrollingInterests | -352.00M | -305.00M | -248.00M | 15.00M |
| NetIncomeContinuousOperations | -352.00M | -305.00M | -248.00M | 15.00M |
| TaxProvision | 35.00M | 71.00M | 82.00M | 58.00M |
| PretaxIncome | -317.00M | -234.00M | -166.00M | 73.00M |
| OtherIncomeExpense | -96.00M | -56.00M | -102.00M | -7.00M |
| OtherNonOperatingIncomeExpenses | -1.00M | 1.00M | ||
| SpecialIncomeCharges | -81.00M | -44.00M | -74.00M | -13.00M |
| GainOnSaleOfPPE | 6.00M | 5.00M | 0.00 | 0.00 |
| OtherSpecialCharges | 49.00M | 23.00M | 3.00M | 2.00M |
| WriteOff | 12.00M | |||
| ImpairmentOfCapitalAssets | 0.00 | 5.00M | 0.00 | 1.00M |
| RestructuringAndMergernAcquisition | 38.00M | 21.00M | 71.00M | 10.00M |
| GainOnSaleOfSecurity | -15.00M | -12.00M | -28.00M | 6.00M |
| NetNonOperatingInterestIncomeExpense | -409.00M | -384.00M | -268.00M | -140.00M |
| InterestExpenseNonOperating | 421.00M | 399.00M | 283.00M | 146.00M |
| InterestIncomeNonOperating | 12.00M | 15.00M | 15.00M | 6.00M |
| OperatingIncome | 188.00M | 206.00M | 204.00M | 220.00M |
| OperatingExpense | 2.86B | 2.71B | 2.30B | 2.03B |
| DepreciationAmortizationDepletionIncomeStatement | 258.00M | 288.00M | 240.00M | 244.00M |
| DepreciationAndAmortizationInIncomeStatement | 258.00M | 288.00M | 240.00M | 244.00M |
| Amortization | 258.00M | 288.00M | 240.00M | 244.00M |
| AmortizationOfIntangiblesIncomeStatement | 258.00M | 288.00M | 240.00M | 244.00M |
| ResearchAndDevelopment | 371.00M | 343.00M | 324.00M | 307.00M |
| SellingGeneralAndAdministration | 2.23B | 2.08B | 1.74B | 1.48B |
| GrossProfit | 3.05B | 2.92B | 2.50B | 2.25B |
| CostOfRevenue | 2.05B | 1.87B | 1.64B | 1.52B |
| TotalRevenue | 5.10B | 4.79B | 4.15B | 3.77B |
| OperatingRevenue | 8.39B | 7.49B | 4.13B | 3.75B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 354.21M | 352.40M | 350.91M | 350.00M |
| ShareIssued | 354.21M | 352.40M | 350.91M | 350.00M |
| NetDebt | 4.70B | 4.48B | 4.23B | 2.08B |
| TotalDebt | 5.08B | 4.78B | 4.56B | 2.44B |
| TangibleBookValue | -1.59B | -1.54B | -1.31B | 468.00M |
| InvestedCapital | 11.53B | 11.26B | 11.41B | 9.47B |
| WorkingCapital | 1.06B | 1.05B | 1.16B | 841.00M |
| NetTangibleAssets | -1.59B | -1.54B | -1.31B | 468.00M |
| CommonStockEquity | 6.45B | 6.47B | 6.85B | 7.03B |
| TotalCapitalization | 11.49B | 11.22B | 11.38B | 9.44B |
| TotalEquityGrossMinorityInterest | 6.52B | 6.54B | 6.92B | 7.10B |
| MinorityInterest | 71.00M | 71.00M | 70.00M | 68.00M |
| StockholdersEquity | 6.45B | 6.47B | 6.85B | 7.03B |
| OtherEquityInterest | 10.36B | |||
| GainsLossesNotAffectingRetainedEarnings | -1.18B | -1.39B | -1.25B | -1.26B |
| OtherEquityAdjustments | -1.18B | -1.39B | -1.25B | -1.26B |
| RetainedEarnings | -931.00M | -571.00M | -254.00M | 6.00M |
| AdditionalPaidInCapital | 8.56B | 8.43B | 8.35B | 8.29B |
| CapitalStock | 0.00 | 0.00 | 0.00 | 0.00 |
| CommonStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 7.50B | 6.92B | 6.52B | 4.04B |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 5.58B | 5.19B | 4.94B | 2.75B |
| OtherNonCurrentLiabilities | 521.00M | 430.00M | 397.00M | 329.00M |
| NonCurrentDeferredLiabilities | 19.00M | 13.00M | 14.00M | 7.00M |
| NonCurrentDeferredTaxesLiabilities | 19.00M | 13.00M | 14.00M | 7.00M |
| LongTermDebtAndCapitalLeaseObligation | 5.04B | 4.74B | 4.53B | 2.41B |
| LongTermDebt | 5.04B | 4.74B | 4.53B | 2.41B |
| CurrentLiabilities | 1.92B | 1.74B | 1.58B | 1.30B |
| OtherCurrentLiabilities | 487.00M | 427.00M | 400.00M | 342.00M |
| CurrentDebtAndCapitalLeaseObligation | 39.00M | 40.00M | 30.00M | 25.00M |
| CurrentDebt | 39.00M | 40.00M | 30.00M | 25.00M |
| OtherCurrentBorrowings | 25.00M | |||
| LineOfCredit | 0.00 | 28.00M | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 250.00M | 230.00M | 233.00M | 196.00M |
| CurrentProvisions | 85.00M | 88.00M | ||
| PayablesAndAccruedExpenses | 1.14B | 1.04B | 916.00M | 733.00M |
| CurrentAccruedExpenses | 756.00M | 652.00M | 394.00M | 363.00M |
| InterestPayable | 57.00M | 35.00M | ||
| Payables | 388.00M | 389.00M | 522.00M | 370.00M |
| AccountsPayable | 388.00M | 389.00M | 522.00M | 370.00M |
| TotalAssets | 14.02B | 13.47B | 13.44B | 11.14B |
| TotalNonCurrentAssets | 11.04B | 10.68B | 10.70B | 9.01B |
| OtherNonCurrentAssets | 310.00M | 294.00M | 225.00M | 215.00M |
| NonCurrentDeferredAssets | 934.00M | 885.00M | 921.00M | 927.00M |
| NonCurrentDeferredTaxesAssets | 934.00M | 885.00M | 921.00M | 927.00M |
| GoodwillAndOtherIntangibleAssets | 8.04B | 8.02B | 8.16B | 6.57B |
| OtherIntangibleAssets | 3.28B | 3.49B | 3.59B | 2.06B |
| Goodwill | 4.76B | 4.52B | 4.58B | 4.51B |
| NetPPE | 1.76B | 1.49B | 1.39B | 1.30B |
| AccumulatedDepreciation | -1.90B | -1.68B | -1.63B | -1.51B |
| GrossPPE | 3.66B | 3.17B | 3.02B | 2.81B |
| Leases | 400.00M | 362.00M | 347.00M | 335.00M |
| ConstructionInProgress | 525.00M | 458.00M | 347.00M | 237.00M |
| OtherProperties | 335.00M | 232.00M | ||
| MachineryFurnitureEquipment | 1.94B | 1.67B | 1.66B | 1.58B |
| BuildingsAndImprovements | 743.00M | 632.00M | 624.00M | 614.00M |
| LandAndImprovements | 47.00M | 43.00M | 45.00M | 44.00M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 2.98B | 2.79B | 2.74B | 2.14B |
| OtherCurrentAssets | 383.00M | 410.00M | 541.00M | 405.00M |
| RestrictedCash | 14.00M | 11.00M | 3.00M | 26.00M |
| PrepaidAssets | 405.00M | 165.00M | ||
| Inventory | 976.00M | 1.04B | 1.03B | 628.00M |
| FinishedGoods | 635.00M | 675.00M | 667.00M | 421.00M |
| WorkInProcess | 98.00M | 99.00M | 100.00M | 44.00M |
| RawMaterials | 243.00M | 262.00M | 261.00M | 163.00M |
| Receivables | 1.22B | 1.03B | 839.00M | 724.00M |
| AccountsReceivable | 1.22B | 1.03B | 839.00M | 724.00M |
| AllowanceForDoubtfulAccountsReceivable | -17.00M | -18.00M | -21.00M | -22.00M |
| GrossAccountsReceivable | 1.24B | 1.04B | 860.00M | 746.00M |
| CashCashEquivalentsAndShortTermInvestments | 383.00M | 305.00M | 331.00M | 354.00M |
| CashAndCashEquivalents | 383.00M | 305.00M | 331.00M | 354.00M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -66.00M | -59.00M | -198.00M | 170.00M |
| RepaymentOfDebt | -3.10B | -430.00M | -161.00M | -13.00M |
| IssuanceOfDebt | 3.36B | 631.00M | 2.28B | 2.47B |
| CapitalExpenditure | -349.00M | -291.00M | -181.00M | -175.00M |
| InterestPaidSupplementalData | 380.00M | 415.00M | 238.00M | 132.00M |
| IncomeTaxPaidSupplementalData | 59.00M | 91.00M | 64.00M | 83.00M |
| EndCashPosition | 397.00M | 316.00M | 334.00M | 380.00M |
| BeginningCashPosition | 316.00M | 334.00M | 380.00M | 177.00M |
| EffectOfExchangeRateChanges | 28.00M | -16.00M | 2.00M | -8.00M |
| ChangesInCash | 53.00M | -2.00M | -48.00M | 211.00M |
| FinancingCashFlow | 225.00M | 178.00M | 2.08B | 81.00M |
| CashFlowFromContinuingFinancingActivities | 225.00M | 178.00M | 2.08B | 81.00M |
| NetOtherFinancingCharges | -36.00M | -23.00M | -37.00M | -2.38B |
| NetIssuancePaymentsOfDebt | 261.00M | 201.00M | 2.12B | 2.46B |
| NetLongTermDebtIssuance | 261.00M | 201.00M | 2.12B | 2.46B |
| LongTermDebtPayments | -3.10B | -430.00M | -161.00M | -13.00M |
| LongTermDebtIssuance | 3.36B | 631.00M | 2.28B | 2.47B |
| InvestingCashFlow | -455.00M | -412.00M | -2.11B | -215.00M |
| CashFlowFromContinuingInvestingActivities | -455.00M | -412.00M | -2.11B | -215.00M |
| NetOtherInvestingChanges | 7.00M | 2.00M | 1.00M | |
| InterestReceivedCFI | 12.00M | 13.00M | 13.00M | 0.00 |
| NetInvestmentPurchaseAndSale | -3.00M | 2.00M | -1.00M | 5.00M |
| SaleOfInvestment | 8.00M | 14.00M | 16.00M | 22.00M |
| PurchaseOfInvestment | -11.00M | -12.00M | -17.00M | -17.00M |
| NetBusinessPurchaseAndSale | -122.00M | -138.00M | -1.94B | -45.00M |
| PurchaseOfBusiness | -122.00M | -138.00M | -1.94B | -45.00M |
| NetIntangiblesPurchaseAndSale | 0.00 | -16.00M | ||
| PurchaseOfIntangibles | 0.00 | -16.00M | ||
| NetPPEPurchaseAndSale | -349.00M | -291.00M | -181.00M | -175.00M |
| PurchaseOfPPE | -349.00M | -291.00M | -181.00M | -175.00M |
| OperatingCashFlow | 283.00M | 232.00M | -17.00M | 345.00M |
| CashFlowFromContinuingOperatingActivities | 283.00M | 232.00M | -17.00M | 345.00M |
| ChangeInWorkingCapital | 18.00M | -87.00M | -287.00M | -19.00M |
| ChangeInPayablesAndAccruedExpense | 108.00M | 126.00M | 245.00M | 189.00M |
| ChangeInPayable | 108.00M | 126.00M | 245.00M | 189.00M |
| ChangeInAccountPayable | 108.00M | 126.00M | 245.00M | 189.00M |
| ChangeInPrepaidAssets | 20.00M | 161.00M | -147.00M | -7.00M |
| ChangeInInventory | 38.00M | -147.00M | -264.00M | -106.00M |
| ChangeInReceivables | -148.00M | -227.00M | -121.00M | -95.00M |
| ChangesInAccountReceivables | -148.00M | -227.00M | -121.00M | -95.00M |
| OtherNonCashItems | 56.00M | 83.00M | 52.00M | -15.00M |
| StockBasedCompensation | 149.00M | 92.00M | 74.00M | 62.00M |
| ProvisionandWriteOffofAssets | 31.00M | 26.00M | 21.00M | 25.00M |
| AssetImpairmentCharge | 0.00 | 5.00M | 0.00 | 1.00M |
| DeferredTax | -32.00M | -10.00M | -10.00M | -90.00M |
| DeferredIncomeTax | -32.00M | -10.00M | -10.00M | -90.00M |
| DepreciationAmortizationDepletion | 421.00M | 436.00M | 382.00M | 379.00M |
| DepreciationAndAmortization | 421.00M | 436.00M | 382.00M | 379.00M |
| AmortizationCashFlow | 382.00M | 379.00M | 415.00M | |
| AmortizationOfIntangibles | 382.00M | 379.00M | 415.00M | |
| OperatingGainsLosses | -8.00M | -8.00M | -1.00M | -13.00M |
| GainLossOnInvestmentSecurities | -10.00M | -13.00M | -13.00M | -6.00M |
| NetForeignCurrencyExchangeGainLoss | 2.00M | 10.00M | 12.00M | -7.00M |
| NetIncomeFromContinuingOperations | -352.00M | -305.00M | -248.00M | 15.00M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for BLCO
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|